Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2007
07/05/2007US20070155789 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
07/05/2007US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine
07/05/2007US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine
07/05/2007US20070155771 Methods and means for treating protein conformational disorders
07/05/2007US20070155762 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
07/05/2007US20070155759 Using 1-acylpiperidine substance P antagonists; gastrointestinal disorders, analgesics, antiinflammatory agents, central nervous system disorders, rheumatic diseases
07/05/2007US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
07/05/2007US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
07/05/2007US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
07/05/2007US20070155719 Platelet ADP receptor inhibitors
07/05/2007US20070155689 Methods of regulating growth and death of cancer cells
07/05/2007US20070155679 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
07/05/2007US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
07/05/2007US20070155670 Pyrrolidine Melanocortin-Specific Compounds
07/05/2007US20070154933 Reagents and Methods for Identifying Gene Targets for Treating Cancer
07/05/2007US20070154908 Connective Tissue Growth Factor-2
07/05/2007US20070154485 Anticancer agents using verotoxin variants
07/05/2007US20070154463 Stem cell originated from salivary gland duct epithelium and use of the same
07/05/2007US20070154451 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells
07/05/2007US20070154428 Thiazole derivative
07/05/2007US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor
07/05/2007DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter
07/05/2007CA2634637A1 Controlled release solid preparation
07/05/2007CA2634542A1 Incontinence treatment methods
07/05/2007CA2634456A1 Modulators of muscarinic receptors
07/04/2007EP1803821A2 Methods for managing kinase inhibitor therapy
07/04/2007EP1803810A1 Integrin antagonists
07/04/2007EP1803730A1 Albumin fusion proteins
07/04/2007EP1803729A1 1-( -d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof
07/04/2007EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
07/04/2007EP1803719A1 1,5-diheterocycle-1h-triazole derivative
07/04/2007EP1803709A1 Proton pump inhibitors
07/04/2007EP1803706A1 HIV protease inhibitors based on amino acid derivatives
07/04/2007EP1803467A1 Composite fine particles and process for producing the same
07/04/2007EP1803448A2 Tasted masked veterinary solid compositions
07/04/2007EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
07/04/2007EP1523318A4 Treatment of human multiple myeloma by curcumin
07/04/2007EP1464636B1 Novel substance having antitumor/anti-inflammatory activity
07/04/2007EP1456189B1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/04/2007EP1414405B1 Invert emulsion containing dhea
07/04/2007EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
07/04/2007EP1339349A4 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
07/04/2007EP1331972B1 Pharmaceutical compositions
07/04/2007EP1311699B1 Adeno-associated virus-mediated delivery of angiogenic factors
07/04/2007EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
07/04/2007EP1260512B1 Novel cyclic amide derivatives
07/04/2007EP1161449B1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
07/04/2007EP1124982B1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i
07/04/2007EP1034301B1 Inhibition of an fgf-binding protein using ribozymes
07/04/2007EP0977750B1 Farnesyltransferase inhibiting quinazolinones
07/04/2007EP0567566B2 Methods for treating tumor necrosis factor mediated diseases
07/04/2007CN1993463A Follistatin mutant polypeptide
07/04/2007CN1993367A Condensed pyrimidine derivative and xanthine oxidase inhibitor
07/04/2007CN1993364A Hexahydro-pyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids
07/04/2007CN1993362A 稠合的杂环化合物 Fused heterocyclic compounds
07/04/2007CN1993118A Aqueous eye drops with accelerated intraocular migration permeability
07/04/2007CN1990504A Earthworm protein suppressing cancer cell accretion by road spectrum
07/04/2007CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor
07/04/2007CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
07/04/2007CN1990471A Mch antagonists and their use in the treatment of obesity
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1989991A Process for preparing rhodiola root extract
07/04/2007CN1989963A Pharmaceutical compositions
07/04/2007CN1989855A Cordyceps sinensis cigarette and process for manufacturing same
07/04/2007CN1324045C Protein separated from jellyfish and possessing antioxygenation activity and its application
07/04/2007CN1324039C New hydrogenated condensed palatinose products
07/04/2007CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics
07/04/2007CN1324025C Tropane derivatives as CCR5 modulators
07/04/2007CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
07/04/2007CN1324022C Inhibitors of tyrosine kinases
07/04/2007CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors
07/04/2007CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
07/04/2007CN1324013C Aryl Fused azapolycyclic compounds
07/04/2007CN1324012C TNF-alpha prodn. inhibitors
07/04/2007CN1324001C Novel thyroid receptor ligands
07/04/2007CN1323719C Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker
07/04/2007CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma
07/04/2007CN1323702C Compound Chinese medicine with qi-invigorating blood-nourishing, yin-replenishing body fluid-increasing blood circulation-promoting and stasis-removing functions and its production method
07/04/2007CN1323672C Cell growth regulatory factor C and preparing process thereof
07/04/2007CN1323671C Cell growth regulating factor J and its prepn process
07/04/2007CN1323670C Cell growth regulatory factor L and preparing process thereof
07/04/2007CN1323669C Cell growth regulating factor P and its prepn process
07/04/2007CN1323658C Novel dry powder inhalation system for transpulmonary administration
07/04/2007CN1323654C Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride
07/04/2007CN1323594C Method for preparing milk powder contg. micron ginseng, tortoise, pearl and pollen for tonifying-Yin, dispelling-fatigue and enriching-calcium
07/03/2007US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents
07/03/2007US7238811 Chemical compounds
07/03/2007US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor
07/03/2007US7238796 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem
07/03/2007US7238723 Indole derivatives
07/03/2007US7238718 Method for treating myolytic disease and method for screening antimyolytic agent
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007US7238716 Alkanoic acid derivatives process for their production and use thereof
07/03/2007US7238712 Indole-type derivatives as inhibitors of p38 kinase
07/03/2007US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
07/03/2007US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
07/03/2007US7238700 A2B adenosine receptor antagonists
07/03/2007US7238695 Imidazolyl derivatives